A comprehensive view of BioNTech SE. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

EU in discussions with Pfizer, BioNTech about possibly reducing the 500 million COVID-19 vaccine purchases it has committed to buying this year or extending the deadline in exchange for a higher price; there is currently a glut of excess vaccines globally
Published: January 27, 2023 by International Business Times
US Patent Issued to TRON-Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz gGmbH, BioNTech on Jan. 24 for "RNA formulation for immunotherapy" (German Inventors)
Published: January 25, 2023 by U.S. Fed News
INTERNATIONAL PATENT: BIONTECH SE FILES APPLICATION FOR "AGENTS ENCODING CLDN6 AND CD3 BINDING ELEMENTS FOR TREATING CLDN6-POSITIVE CANCERS"
Published: January 23, 2023 by U.S. Fed News
INTERNATIONAL PATENT: BIONTECH SE, GENMAB A/S FILES APPLICATION FOR "MULTISPECIFIC BINDING AGENTS AGAINST CD40 AND CD137 IN COMBINATION THERAPY FOR CANCER"
Published: January 23, 2023 by U.S. Fed News
US Patent Issued to BioNTech on Jan. 10 for "Coronavirus vaccine" (German Inventors)
Published: January 22, 2023 by U.S. Fed News

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count